Procaspase Activating Compounds


Compositions and methods are disclosed in embodiments relating to induction of cell death such as in cancer cells. Compounds and related methods for synthesis and use thereof, including the use of compounds in therapy for the treatment of cancer and selective induction of apoptosis in cells are disclosed. Compounds are disclosed that have lower neurotoxicity effects than other compounds.

Download PDF
Document Preview
Document History
  • Publication: May 9, 2017
  • Application: Aug 10, 2015
    US US 201514822830 A
  • Priority: Aug 10, 2015
    US US 201514822830 A
  • Priority: Jul 1, 2014
    US US 201414321514 A
  • Priority: Nov 2, 2011
    US US 201113148350 A
  • Priority: Feb 9, 2010
    US US 2010/0023543 W
  • Priority: Feb 9, 2009
    US US 15106409 P

Download Citation

Sign in to the Lens